Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.005 CHF | -2.51% |
|
+5.26% | -64.94% |
Jul. 11 | DOCMORRIS : Receives a Buy rating from Jefferies | ZD |
Jul. 03 | DOCMORRIS : Deutsche Bank reaffirms its Neutral rating | ZD |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Online Drug Retail and Pharmacies | ||||||||||
Germany | 821M | 1.02B | 859M | 907M | 954M | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | 37.02M | -14.92M | -47.95M | -31.84M | -47.2M | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Europe | 66.41M | 81.94M | 70.45M | 62.08M | 63.1M | |||||
EBITDA | -3.93M | -13.92M | -9.74M | -3.04M | -1.4M | |||||
Corporate | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | -31.78M | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
EBITDA | -151M | -157M | - | - | - | |||||
EBITDA | 2.04M | 2.76M | - | - | - | |||||
Brand Doc Morris | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Brand Zur Rose | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Eliminations | -3.81M | -6.99M | -7.52M | - | - | |||||
Total Assets | - | - | - | - | - | |||||
EBITDA | -3.81M | -6.94M | -2.36M | - | - | |||||
Drug Stores and Pharmacies | ||||||||||
Switzerland | 593M | 627M | 687M | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | 41.48M | 47.27M | 22.14M | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Germany | 821M | 1.02B | 859M | 907M | 954M | |||||
Total Assets | 311M | 295M | 172M | 156M | 149M | |||||
Other | 66.41M | 81.88M | 70.45M | 62.08M | 63.1M | |||||
Total Assets | 5.35M | 5.88M | 5.88M | 4.91M | 4.26M | |||||
Total Assets | 269M | 266M | 358M | 330M | 329M | |||||
Switzerland | 589M | 620M | 679M | - | - | |||||
Total Assets | 116M | 128M | 133M | 65.88M | 62.81M |
- Stock Market
- Equities
- ROSE Stock
- Financials DocMorris AG
- Business Segments
Select your edition
All financial news and data tailored to specific country editions